190 related articles for article (PubMed ID: 15750593)
1. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer.
Sun X; Frierson HF; Chen C; Li C; Ran Q; Otto KB; Cantarel BL; Vessella RL; Gao AC; Petros J; Miura Y; Simons JW; Dong JT
Nat Genet; 2005 Apr; 37(4):407-12. PubMed ID: 15750593
[TBL] [Abstract][Full Text] [Related]
2. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of the ATBF1 gene in gastric cancer.
Cho YG; Song JH; Kim CJ; Lee YS; Kim SY; Nam SW; Lee JY; Park WS
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4355-9. PubMed ID: 17671116
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer.
Kai K; Zhang Z; Yamashita H; Yamamoto Y; Miura Y; Iwase H
BMC Cancer; 2008 Sep; 8():262. PubMed ID: 18796146
[TBL] [Abstract][Full Text] [Related]
6. Germline ATBF1 mutations and prostate cancer risk.
Xu J; Sauvageot J; Ewing CM; Sun J; Liu W; Isaacs SD; Wiley KE; Diaz L; Zheng SL; Walsh PC; Isaacs WB
Prostate; 2006 Jul; 66(10):1082-5. PubMed ID: 16637072
[TBL] [Abstract][Full Text] [Related]
7. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
Riou P; Saffroy R; Comoy J; Gross-Goupil M; Thiéry JP; Emile JF; Azoulay D; Piatier-Tonneau D; Lemoine A; Debuire B
Clin Cancer Res; 2002 Oct; 8(10):3178-86. PubMed ID: 12374686
[TBL] [Abstract][Full Text] [Related]
8. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
[TBL] [Abstract][Full Text] [Related]
9. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
[TBL] [Abstract][Full Text] [Related]
10. Prevalent mutations in prostate cancer.
Dong JT
J Cell Biochem; 2006 Feb; 97(3):433-47. PubMed ID: 16267836
[TBL] [Abstract][Full Text] [Related]
11. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
12. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
[TBL] [Abstract][Full Text] [Related]
13. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
[TBL] [Abstract][Full Text] [Related]
14. Infrequent mutation of ATBF1 in human breast cancer.
Sun X; Zhou Y; Otto KB; Wang M; Chen C; Zhou W; Subramanian K; Vertino PM; Dong JT
J Cancer Res Clin Oncol; 2007 Feb; 133(2):103-5. PubMed ID: 16932943
[TBL] [Abstract][Full Text] [Related]
15. KLF6, a candidate tumor suppressor gene mutated in prostate cancer.
Narla G; Heath KE; Reeves HL; Li D; Giono LE; Kimmelman AC; Glucksman MJ; Narla J; Eng FJ; Chan AM; Ferrari AC; Martignetti JA; Friedman SL
Science; 2001 Dec; 294(5551):2563-6. PubMed ID: 11752579
[TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1.
Kataoka H; Miura Y; Joh T; Seno K; Tada T; Tamaoki T; Nakabayashi H; Kawaguchi M; Asai K; Kato T; Itoh M
Oncogene; 2001 Feb; 20(7):869-73. PubMed ID: 11314020
[TBL] [Abstract][Full Text] [Related]
17. AT motif binding factor 1-A (ATBF1-A) negatively regulates transcription of the aminopeptidase N gene in the crypt-villus axis of small intestine.
Kataoka H; Joh T; Miura Y; Tamaoki T; Senoo K; Ohara H; Nomura T; Tada T; Asai K; Kato T; Itoh M
Biochem Biophys Res Commun; 2000 Jan; 267(1):91-5. PubMed ID: 10623580
[TBL] [Abstract][Full Text] [Related]
18. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
20. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
